Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05202782
Title Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northwestern University
Indications

non-Hodgkin lymphoma

diffuse large B-cell lymphoma

B-cell lymphoma

diffuse large B-cell lymphoma activated B-cell type

diffuse large B-cell lymphoma germinal center B-cell type

primary mediastinal B-cell lymphoma

Therapies

Zanubrutinib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.